{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:25:43Z","timestamp":1783117543108,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jdermsci.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T16:14:07Z","timestamp":1533744847000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effect of levamisole in the treatment of recalcitrant recurrent erythema multiforme major: An observational study"],"prefix":"10.1016","volume":"92","author":[{"given":"Ren-Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline C.Y.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Zon","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdermsci.2018.08.002_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007","volume":"62","author":"Wetter","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-198905000-00001","article-title":"Recurrent erythema multiforme","volume":"68","author":"Huff","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","article-title":"Levamisole in dermatology: A review","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.08.002_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0378-6323.175927","article-title":"Levamisole: A multi-faceted drug in dermatology","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/137.5.597","article-title":"A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis","volume":"137","author":"Russell","year":"1978","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0035","first-page":"352","article-title":"Double-blind cross-over study of levamisole as immunoprophylaxis for recurrent herpes progenitalis","volume":"21","author":"Bierman","year":"1978","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1977.tb21947.x","article-title":"Correlation of clinical and virus-specific immune responses following levamisole therapy of recurrent herpes progenitalis","volume":"284","author":"O\u2019Reilly","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0192-0561(80)90011-9","article-title":"Clinical and immunologic responses to levamisole in 13 patients with erythema multiforme","volume":"2","author":"Lozada","year":"1980","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0030-4220(82)90482-0","article-title":"Levamisole in the treatment of erythema multiforme: a double-blind trial in fourteen patients","volume":"53","author":"Lozada","year":"1982","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0030-4220(92)90062-U","article-title":"Clinical response to levamisole in thirty-nine patients with erythema multiforme: an open prospective study","volume":"74","author":"Lozada-Nur","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0060","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1200\/JCO.1995.13.12.2936","article-title":"Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II\/Dukes B2 colon cancer","volume":"13","author":"Moertel","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jdermsci.2018.08.002_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1042\/CS20140749","article-title":"Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte","volume":"128","author":"Jiang","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00467-017-3616-5","article-title":"Efficacy of higher-dose levamisole in maintaining remission in steroid-dependent nephrotic syndrome","volume":"32","author":"Abeyagunawardena","year":"2017","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.08.002_bib0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s13365-013-0189-3","article-title":"Immunological control of herpes simplex virus infections","volume":"19","author":"Egan","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature12110","article-title":"Immune surveillance by CD8\u03b1\u03b1+ skin-resident T cells in human herpes virus infection","volume":"497","author":"Zhu","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jdermsci.2018.08.002_bib0085","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/infdis\/jit383","article-title":"Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions","volume":"208","author":"Chung","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0090","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1046\/j.1365-2133.2000.03566.x","article-title":"Claudy A Recurrent erythema multiforme and chronic hepatitis C efficacy of interferon alpha","volume":"142","author":"Dumas","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003495-198020020-00001","article-title":"The general immunopharmacology of levamisole","volume":"19","author":"Renoux","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0192-0561(91)90019-4","article-title":"On the biochemical mode of action of levamisole: an update","volume":"13","author":"Van Wauwe","year":"1991","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.intimp.2015.12.015","article-title":"Levamisole promotes murine bone marrow derived dendritic cell activation and drives Th1 immune response in vitro and in vivo","volume":"31","author":"Fu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/sji.12018","article-title":"Synergistic and additive effects of cimetidine and levamisole on cellular immune responses to hepatitis B virus DNA vaccine in mice","volume":"77","author":"Niu","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br. J. Dermatol."},{"issue":"1 Pt 2","key":"10.1016\/j.jdermsci.2018.08.002_bib0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0190-9622(88)70027-4","article-title":"Acyclovir for recurrent erythema multiforme caused by herpes simplex","volume":"18","author":"Huff","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1440-0960.2004.00130.x","article-title":"Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme","volume":"46","author":"Bakis","year":"2005","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0130","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/archderm.138.12.1547","article-title":"Recurrent erythema multiforme\/Stevens-Johnson syndrome: response to mycophenolate mofetil","volume":"138","author":"Davis","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.08.002_bib0135","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12449","article-title":"Treatment of antiviral-resistant recurrent erythema multiforme with dapsone","volume":"30","author":"Oak","year":"2017","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.08.002_bib0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdcr.2016.11.009","article-title":"Treatment of recurrent erythema multiforme with adalimumab as monotherapy","volume":"3","author":"Baillis","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0145","first-page":"1721","article-title":"Adverse reactions to levamisole","volume":"62","author":"Symoens","year":"1978","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.jdermsci.2018.08.002_bib0150","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","article-title":"Characteristic purpura of the ears, vasculitis, and neutropenia\u2014a potential public health epidemic associated with levamisole-adulterated cocaine","volume":"65","author":"Chung","year":"2011","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118303025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118303025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T19:51:11Z","timestamp":1538164271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118303025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0923181118303025"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.002","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of levamisole in the treatment of recalcitrant recurrent erythema multiforme major: An observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}